H.E.R.O.S. Study: An Observational Study of the Cardiac Safety of Herceptin (Trastuzumab) in Patients With HER2-Positive Breast Cancer
Clinical trial NCT01991340 · COMPLETED
Trial details
- NCT number
- NCT01991340
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2008-11-01
- Primary completion
- 2013-02-01
- Enrollment
- 657
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.